摘要:
The present invention relates to a hypertonia gene located on chromosome 12p in the genomic region between genome markers AFM338WH5 and D12S1057 and uses of such a gene.
摘要:
The present invention relates to an in vitro method for diagnosing a genetic predisposition or susceptibility for a cardiovascular disease, condition or disorder in a mammal which comprises detecting of at least three particular single nucleotide polymorphisms (SNP) in a sample obtained from said mammal in at least one of a genomic locus-derived nucleic acid or fragment thereof of the loci APOB, APOE, ABCA1, CETP, LCAT, LIPC, LPL, LDLR, APOC2, APOA5, APOA4, APOC3, and APOA1. Furthermore, the present invention relates to the improved diagnosis that is based on the analysis of several haplotypes for the above-mentioned loci (i.e. a combination of said haplotypes).
摘要:
This invention comprises a device for detecting and measuring a gas component of a gas mixture using the optical-pneumatic effect produced by absorption of infrared radiation by a gas. The device comprises, in optical alignment, a radiation source, filter means, a cuvette system and a receiver unit which contains a measuring chamber and a comparison chamber. Pressure differential means such as a diaphragm condenser measures the opticalpneumatic effect produced by the absorption of radiation. The device is provided with porous means for flow of gases to eliminate interfering fluctuations in gas flow.
摘要:
The present invention relates to the use of an angiotensin II type 1 receptor antagonist in the manufacture of a medicament for the prophylactic and/or therapeutic treatment of cardiovascular complications encountered in a patient in need of dialysis. The invention further relates to a method for prophylactic and/or therapeutic treatment of cardiovascular complications encountered in a patient in need of dialysis, comprising administering to the patient a therapeutically effective amount of an angiotensin II type 1 receptor antagonist.
摘要:
A radiation receiver including three receiver layers for infrared gas analysis. The first and third layers are connected in parallel, and their pressure is compared with that of the second or middle layer to derive a pressure difference which compensates for certain measurement problems found in prior art devices.
摘要:
The invention relates to the application of the direct correlation between the overexpression or the functional molecular modification of human homologs of the sgk family and hypertension for quantitative diagnosis of a particular form of genetically determined hypertension. In particular the invention relates to the detection of a direct link between two different polymorphisms of individual nucleotides in the hsgk1 gene and the genetically determined predisposition to hypertension. The invention further relates to the provision of a diagnostic kit containing antibodies or polynucleotides for detecting the diagnostic targets hsgk1, hsgk2 and hsgk3.
摘要:
An auxiliary signal for the compensation of the difference signal created in optical-pneumatic receivers due to the absorption of radiation, such compensation being achieved by one or more electrical-pneumatic transmitters connected directly to the receiver chambers.
摘要:
Disclosed are peptides of the AT1 receptor and their use for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension. The peptides may, for example, be used for the diagnosis of preeclampsia. Peptides having the sequence AFHYESQ (SEQ ID NO: 1), AVHYQSN (SEQ ID NO: 2), SHFYQTR (SEQ ID NO: 3), GYYFDTN (SEQ ID NO: 4) or ENTNIT (SEQ ID NO: 5) are preferred.
摘要翻译:公开了AT1受体的肽及其在先兆子痫和恶性高血压中消除特异性结合的,细胞 - 生理活性的病理学抗体的用途。 肽可以例如用于先兆子痫的诊断。 具有序列AFHYESQ(SEQ ID NO:1),AVHYQSN(SEQ ID NO:2),SHFYQTR(SEQ ID NO:3),GYYFDTN(SEQ ID NO:4)或ENTNIT(SEQ ID NO:5)的肽是优选的 。